Description
The Access SARS-CoV-2 IgG antibody test detects antibodies to the RBD (Receptor Binding Domain) of the spike protein and can be run in random access mode, seamlessly integrating into current laboratory workflow without the need for batching or special maintenance. The test features market-leading sensitivity and specificity along with its throughput on Beckman Coulter immunoassay and integrated systems leading the industry at up to 200 tests per hour depending on the analyzer used (up to 4,800 tests/day).
Request Information
Specifications
• Assay Format: 2x100 determinations
• Calibrator Format: C0-C1, 1 vial/kit, 2mL/vial
• QC Format: QC1-QC2, 3 vials/kit, 4mL/vial
• Sample volume: 20uL
• Open pack stability: 28 days
• Calibration stability: 28 days
• Time-to-first result (approx.): 25 minutes
Request Information